ProfileGDS5678 / 1455952_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 11% 11% 11% 12% 12% 10% 10% 11% 11% 11% 11% 11% 11% 11% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.2858811
GSM967853U87-EV human glioblastoma xenograft - Control 22.2776611
GSM967854U87-EV human glioblastoma xenograft - Control 32.2778911
GSM967855U87-EV human glioblastoma xenograft - Control 42.2495112
GSM967856U87-EV human glioblastoma xenograft - Control 52.2423512
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.2974210
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.2726510
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.2606211
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.2577111
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.2704711
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.2632111
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.2604911
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.2711611
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.2667211